Peer-reviewedCC BYFrontiers in oncology
FDX1 is associated with CALR abundance and JAK–STAT-related inflammatory signaling in myeloproliferative neoplasms
- 1Department of Hematology, The Second People’s Hospital of Kashgar , ,
Related
- TLR2 Signaling in Myeloproliferative Neoplasms: Pathophysiological Roles, Mutation-Dependent Heterogeneity, and the Differential Efficacy of Ruxolitinib
- PLATELET CYTOSKELETAL AND SIGNALING-RELATED PATHWAYS ARE TRANSCRIPTIONALLY SUPPRESSED IN PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
- CIRCULATING INFLAMMATORY MEDIATORS REPROGRAM PLATELETS TOWARD A PRO-COAGULANT PHENOTYPE IN PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
- Allele burden expansion in JAK2 V617F and CALR ‐mutated myeloproliferative neoplasms predicts disease progression and is associated with anagrelide treatment
- The JAK2 V617F revolution in myeloproliferative neoplasms.
BibTeX
@article{abuduaini2026fdx1,
title = {{FDX1 is associated with CALR abundance and JAK–STAT-related inflammatory signaling in myeloproliferative neoplasms}},
author = {Diyaer Abuduaini and Diernu Simayi and Mihelayi Maimaiti and Yinglan Feng and Yixia Wang},
journal = {Frontiers in oncology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13655011},
note = {CC BY},
}
RIS
TY - JOUR
TI - FDX1 is associated with CALR abundance and JAK–STAT-related inflammatory signaling in myeloproliferative neoplasms
AU - Diyaer Abuduaini
AU - Diernu Simayi
AU - Mihelayi Maimaiti
AU - Yinglan Feng
AU - Yixia Wang
PY - 2026
DA - 2026/10/16
JO - Frontiers in oncology
UR - https://europepmc.org/article/PMC/PMC13655011
SN - 2234-943X
ER -